Immunoblot assays also revealed the elevated expression levels of LC3A/B after nimbolide exposure in the pancreatic cancer cells (Fig. 4e, Supplementary Fig. S3e and S4e). The gene discussed is MAP1LC3A; the disease is familial pancreatic carcinoma.